Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JP15K09035)
- Takeda Science Foundation
- Japan Agency for Medical Research and Development (JP18fk0210009)
- Japan Agency for Medical Research and Development (JP18fk0310112)
This publication has 46 references indexed in Scilit:
- Biological Significance of Local TGF-β Activation in Liver DiseasesFrontiers in Physiology, 2012
- TGF-β in progression of liver diseaseCell and tissue research, 2011
- Hepatitis C Virus Regulates Transforming Growth Factor β1 Production Through the Generation of Reactive Oxygen Species in a Nuclear Factor κB–Dependent MannerGastroenterology, 2010
- GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3 + regulatory T cellsProceedings of the National Academy of Sciences, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- FIB-4Hepatology, 2007
- Emerging insights into Transforming growth factor Smad signal in hepatic fibrogenesisGut, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996